Riskpilot← Back to searchSign inGet full accessNAVAMEDIC AS
ASActiveOrg 920969836Henrik Ibsens Gate 100, 0255 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20180 employees
Revenue 2024
NOK 201,6M
-7% vs 2023
EBITDA margin
20.4%
-18% vs 2023
Equity ratio
73.4%
Financial strength
Net profit 2024
NOK 38,5M
-9% vs 2023
| Revenue | NOK 201,6M | -7% |
| EBITDA | NOK 41,2M | -18% |
| Net profit | NOK 38,5M | -9% |
| Total assets | NOK 197,1M | -16% |
| Equity | NOK 144,8M | +8% |
| Employees | 0 | — |
Legal name
NAVAMEDIC AS
Org number
920969836
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9. juni 2018
Share capital
NOK 1 480 202
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikle og markedsføre legemidler og andre produkter innen forbrukerhelse, utføre konsulenttjenester i denne sammenheng, og investere i relatert virksomhet.
Address
Henrik Ibsens Gate 100, 0255 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 200 505 | 215 624 | 201 580 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −110 | −23 | 78 248 | 50 426 | 41 202 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −110 | −23 | 78 248 | 50 426 | 41 202 |
| Net financials | 0 | 0 | −738 | 3 707 | 8 109 |
| Profit before tax | −110 | −23 | 77 510 | 54 133 | 49 311 |
| Tax | 74 | −0 | 16 935 | 11 909 | 10 858 |
| Net profit | −184 | −23 | 60 575 | 42 223 | 38 453 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 159 | 135 | 200 044 | 234 362 | 197 089 |
| Equity | 154 | 130 | 124 185 | 133 987 | 144 760 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 5 | 75 858 | 100 375 | 52 330 |
| Total debt | 5 | 5 | 75 858 | 100 375 | 52 330 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20202024
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
20202024
Return on equity
26.6%
This company
18.4%
Market median
+45% vs market
20202024
Net profit margin
19.1%
This company
8.1%
Market median
+136% vs market
20202024
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20202024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Navamedic Asa
NAVAMEDIC AS Board members of NAVAMEDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kathrine Elisabeth Gamborg Andreassen | Chairman | 0 companies |
| Nils Ole Krekling | Board of Directors | 0 companies |
| Lars Hjarrand | Board of Directors | 0 companies |
| Astrid Johanne Torgersen Bratvedt | Board of Directors | 0 companies |
| Ole Henrik Eriksen | Board of Directors | 0 companies |